Discover the latest products from our portfolio
We are pleased to announce a further expansion of our portfolio with the introduction of several new products for the development of diagnostic assays:
Viruses have the ability to change and mutate over time, known as variants. Mutations occurring in the spike protein are of greatest interest, as antibody neutralization and ACE-2 receptor binding may be affected. There are currently several SARS-CoV-2 variants of concern circulating around the globe. These variants are more transmissible and may contribute to an increase of cases. There is also a concern that variants may reduce the effectiveness of treatments and immunization.
We are pleased to offer high quality SARS-CoV-2 spike protein variants to support COVID-19 disease research, including antibody screening, epidemiology and vaccine effectivity studies:
- India (Delta) variant B.1.617.1, catalog number LA777
- UK (Alpha) variant B.1.1.7, catalog number LA770
- South Africa (Beta) variant B.1.351, catalog number LA771
- Brazil (Gamma) variant P.1/B.1.1.28, catalog number LA773
Please find more details about our antigens, antibodies and biological products supporting your SARS-CoV-2 related test development: SARS-CoV-2 Related Products | Medix Biochemica
Recombinant chimeric Troponin I antibody
Recombinant antibodies with human constant regions (Fc) can provide additional benefits in IVD tests that require the utmost sensitivity, such as high-sensitivity cardiac Troponin I testing. Medix Biochemica is committed to offering multiple antibody versions to meet all customer needs, and we are delighted to launch recombinant chimeric versions of our top performing cTnI monoclonal antibodies. Complementing our recently launched recombinant monoclonal antibody offering of cTnI RC9701 and cTnI RC9750, we are now introducing MedixMAB cTnI RC9707. These three troponin antibodies all have different binding epitopes in the most stable regions of the Troponin I molecule, and they carry human IgG-derived Fc, to reduce human anti-mouse antibody (HAMA) interference effects.
A new monoclonal antibody for SAA detection
Medix Biochemica is a leading supplier for monoclonal antibodies used in detection of Serum Amyloid A (SAA); an inflammatory biomarker that can be used in IVD tests to study viral infections or systemic inflammation. We are continuously expanding our offering, and we are now proud to inform about another great addition to the portfolio: Anti-human SAA monoclonal antibody 2209, catalog number 100806. This mouse monoclonal antibody is also applicable for veterinary testing; it reacts with feline, canine, and equine SAA proteins.
If you are developing immunoassays for any of these markers, please contact us to discuss your sample evaluation needs. For technical assistance, please get in touch with our global technical support team: moc.acimehcoibxidem@troppushcet.